Accession Number: | 0001209191-21-003235 |
Date: | 2021-01-08 |
Issuer: | NEUROCRINE BIOSCIENCES INC (NBIX) |
Original Submission Date: |
GORMAN KEVIN CHARLES
12780 EL CAMINO REAL
SAN DIEGO, CA 92130
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-01-08 | M | 143,449 | a | $8.66 | 584,520 | direct | ||
COMMON STOCK | 2021-01-08 | S | 143,449 | d | $110.21 | 441,071 | direct | ||
COMMON STOCK | 2021-01-08 | M | 164,801 | a | $8.65 | 605,872 | direct | ||
COMMON STOCK | 2021-01-08 | S | 164,801 | d | $110.22 | 441,071 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
NON-QUALIFIED STOCK OPTION | 8.66 | 2021-01-08 | deemed execution date | M | 143,449 (d) | 2022-01-12 | common stock 143,449 | $8.66 | 0 | direct | ||
NON-QUALIFIED STOCK OPTION | 8.65 | 2021-01-08 | deemed execution date | M | 164,801 (d) | 2023-01-10 | common stock 164,801 | $8.65 | 0 | direct |
ID | footnote |
---|---|
f1 | the disposition reported in this form 4 was effected by a broker pursuant to instructions set forth in a rule 10b5-1 trading plan adopted by the reporting person at least 60 days prior to the transaction date in box 3 above. additionally, issuer policy restricts the reporting person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. |
f2 | represents a weighted average sales price per share. these shares were sold in multiple transactions at prices ranging from $110.00 to $111.24. the reporting person has provided to the issuer, and will provide to any security holder of the issuer or the sec staff, upon request, information regarding the number of shares sold at each price within the range. |
f3 | represents a weighted average sales price per share. these shares were sold in multiple transactions at prices ranging from $110.00 to $111.19. the reporting person has provided to the issuer, and will provide to any security holder of the issuer or the sec staff, upon request, information regarding the number of shares sold at each price within the range. |
f4 | option granted january 12, 2012 and vested monthly over four years. |
f5 | option granted january 10, 2013 and vested monthly over four years. |